IL-18 and IL-18BP as biomarkers for juvenile arthritis and fevers
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study looks at whether measuring certain proteins (IL-18 and IL-18BP) in the blood can help doctors tell the difference between different causes of fever in children, such as juvenile arthritis, autoinflammatory diseases, or serious infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 2 and 18 years old
- Your child has one of the following: juvenile idiopathic arthritis, recurrent fever/autoinflammatory disease, other rheumatic disease, or a severe infection like sepsis, meningitis, urinary tract infection, or pneumonia
- You (as parent or legal guardian) are willing to sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at children with arthritis to better understand their condition using clinical exams, lab tests, and ultrasounds. It may help doctors learn more about different types of juvenile arthritis.
This study tests if removing certain foods can improve arthritis symptoms in children aged 6 to 17. It may be an option if current medicines are not working well or if you want to explore dietary changes.
This study looks at how certain blood markers relate to disease activity in children with juvenile idiopathic arthritis (JIA). It aims to help doctors better understand and track the condition, which could lead to improved care.
This study looks at blood (and related) markers that may reflect inflammation in people with juvenile idiopathic arthritis. It may help doctors better understand disease activity and guide future care for patients who are able to join.
This study looks at levels of certain immune system proteins (IL-6, IL-12, IL-15, and IL-23) in the blood of people with rheumatoid arthritis. It aims to understand how these proteins relate to the disease and may help guide future treatments for better outcomes.
This study follows people with systemic juvenile idiopathic arthritis (sJIA), adult-onset Still’s disease (AOSD), and similar conditions to learn how the illness works over time. It also collects blood and family information to study genetics and explain what causes flare-ups, which may help future care.
Hear when a new Systemic Juvenile Idiopathic Arthritis (sJIA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.